From: Evaluation of chemosensitivity prediction using quantitative dose–response curve classification for highly advanced/relapsed gastric cancer
Tumor Markers
Cases
%
Responded
CEA
Up
6
(46%)
Stable
3
(23%)
54%
Down
4
(31%)
CA19-9
2
(15%)
7
(54%)
85%
Ascites volume
8
(62%)
Diet
62%
0
(0%)
5
(38%)